ATE361360T1 - Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung - Google Patents

Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung

Info

Publication number
ATE361360T1
ATE361360T1 AT99922611T AT99922611T ATE361360T1 AT E361360 T1 ATE361360 T1 AT E361360T1 AT 99922611 T AT99922611 T AT 99922611T AT 99922611 T AT99922611 T AT 99922611T AT E361360 T1 ATE361360 T1 AT E361360T1
Authority
AT
Austria
Prior art keywords
cultivation
same
culture media
animal cells
producing proteins
Prior art date
Application number
AT99922611T
Other languages
English (en)
Inventor
Kazushi Shibuya
Masaru Atsumi
Shigeyuki Tsunakawa
Kaneo Chugai Nogaki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE361360T1 publication Critical patent/ATE361360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT99922611T 1998-06-01 1999-06-01 Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung ATE361360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15095798 1998-06-01

Publications (1)

Publication Number Publication Date
ATE361360T1 true ATE361360T1 (de) 2007-05-15

Family

ID=15508136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922611T ATE361360T1 (de) 1998-06-01 1999-06-01 Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung

Country Status (16)

Country Link
US (2) US6537782B1 (de)
EP (1) EP1085083B1 (de)
JP (1) JP3510858B2 (de)
KR (1) KR100430447B1 (de)
CN (1) CN1187441C (de)
AT (1) ATE361360T1 (de)
AU (1) AU744715B2 (de)
CA (1) CA2333966C (de)
DE (1) DE69935978T2 (de)
DK (1) DK1085083T3 (de)
ES (1) ES2285840T3 (de)
HK (1) HK1037678A1 (de)
IL (1) IL139974A (de)
NO (2) NO326180B1 (de)
RU (2) RU2214455C2 (de)
WO (1) WO1999063058A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
CA2395271A1 (en) * 1999-12-28 2001-07-05 Isotis N.V. Cell culture medium containing growth factors and l-glutamine
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
DE10124820A1 (de) 2001-05-21 2002-12-05 Heinrich Wieland Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut
EP2311489A3 (de) 2002-02-14 2013-08-21 Chugai Seiyaku Kabushiki Kaisha Formularierung Antikörper-enthaltender Lösungen die einen Zucker als Stabilisator beinhalten.
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
WO2005090405A1 (ja) 2004-03-24 2005-09-29 Chugai Seiyaku Kabushiki Kaisha インターロイキン－６受容体に対するヒト型化抗体のサブタイプ
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
KR100679112B1 (ko) * 2004-11-17 2007-02-07 삼성정밀화학 주식회사 동물세포 배양방법
EP1835022B1 (de) * 2005-01-05 2015-02-11 Chugai Seiyaku Kabushiki Kaisha Zellkulturverfahren und dessen nutzung
WO2007070315A2 (en) 2005-12-08 2007-06-21 Amgen Inc. Improved production of glycoproteins using manganese
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
PE20091174A1 (es) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
JP5711751B2 (ja) 2009-10-26 2015-05-07 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ グリコシル化された免疫グロブリンの調製方法
MD191Z5 (ro) * 2010-01-21 2010-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Mediu nutritiv pentru cultivarea celulelor de origine animală
MX2013005024A (es) 2010-11-08 2013-11-21 Chugai Pharmaceutical Co Ltd Anticuerpo anti-il-6 receptor administrado subcutaneamente.
CA2913687C (en) 2013-07-04 2022-12-13 F. Hoffmann-La Roche Ag Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
CA2928726A1 (en) 2013-10-30 2015-05-07 The Curators Of The University Of Missouri Method for scalable skeletal muscle lineage specification and cultivation
KR20180009760A (ko) 2015-05-27 2018-01-29 아스테라스 세이야쿠 가부시키가이샤 핵산 함유 배지를 이용한 세포 배양 방법
WO2017147169A1 (en) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
WO2018170405A1 (en) 2017-03-17 2018-09-20 Ohio State Innovation Foundation Nanoparticles for delivery of chemopreventive agents
US11976302B2 (en) 2017-05-06 2024-05-07 Upside Foods, Inc. Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
WO2019014652A1 (en) 2017-07-13 2019-01-17 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION
JP2022527972A (ja) 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法
WO2022137357A1 (ja) 2020-12-22 2022-06-30 株式会社マルハチ村松 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS509877B2 (de) * 1972-09-13 1975-04-16
US3962425A (en) * 1972-09-21 1976-06-08 Weyerhaeuser Company Ruminant repellent from enzymatically putrefied lipoidal material
JPS5336033B2 (de) * 1972-12-11 1978-09-30
JPH01148181A (ja) * 1987-12-07 1989-06-09 Jgc Corp グルタチオンの菌体内蓄積法
JPH0239882A (ja) * 1988-07-29 1990-02-08 Japan Synthetic Rubber Co Ltd 動物細胞培養用培地
JPH0638704A (ja) * 1991-06-19 1994-02-15 Morinaga Milk Ind Co Ltd 発酵調味料及びその製造法
US5426045A (en) 1993-12-16 1995-06-20 Sea Run Holdings, Inc. Method for culturing mammalian cells in a medium containing fish serum
WO1995023212A1 (en) 1994-02-23 1995-08-31 Sea Run Holdings, Inc. Method for culturing mammalian cells and insect cells in a medium containing fish serum
CN1157694A (zh) 1996-10-15 1997-08-27 玉环县海天营养源有限公司 一种液化鱼蛋白粉的制作方法

Also Published As

Publication number Publication date
ES2285840T3 (es) 2007-11-16
NO20006096L (no) 2001-02-01
DE69935978T2 (de) 2008-01-17
NO2009012I1 (no) 2009-06-15
CN1309698A (zh) 2001-08-22
AU3958499A (en) 1999-12-20
US6537782B1 (en) 2003-03-25
EP1085083B1 (de) 2007-05-02
RU2333242C2 (ru) 2008-09-10
CN1187441C (zh) 2005-02-02
CA2333966C (en) 2006-07-25
WO1999063058A1 (fr) 1999-12-09
US6962812B2 (en) 2005-11-08
DK1085083T3 (da) 2007-06-18
HK1037678A1 (en) 2002-02-15
AU744715B2 (en) 2002-02-28
KR20010071359A (ko) 2001-07-28
KR100430447B1 (ko) 2004-05-10
CA2333966A1 (en) 1999-12-09
US20030096372A1 (en) 2003-05-22
NO20006096D0 (no) 2000-11-30
EP1085083A1 (de) 2001-03-21
IL139974A0 (en) 2002-02-10
AU744715C (en) 1999-12-20
DE69935978D1 (de) 2007-06-14
NO326180B1 (no) 2008-10-13
IL139974A (en) 2005-09-25
JP3510858B2 (ja) 2004-03-29
EP1085083A4 (de) 2002-11-27
RU2214455C2 (ru) 2003-10-20

Similar Documents

Publication Publication Date Title
ATE361360T1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
ATE258189T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
ATE397059T1 (de) Verfahren zur herstellung von l-lysin oder l- threonin unter verwendung von escherichia- bakterien mit abgeschwächter malatenzymaktivität
ATE213271T1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte- fermentation
ES8700320A1 (es) Metodo de obtencion del exprimido de una materia seleccionada que contiene renina.
DE60335195D1 (de) Mutante e. coli-appa-phytaseenzyme und natürliche varianten davon, solche phytaseenzyme codierende nukleinsäuren, diese enthaltende vektoren und wirtszellen und verfahren zur herstellung und verwendung davon
DE69426723D1 (de) Nährboden zur Züchtung tierischer Zellen oder Zellen die Antikörper produzieren
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
WO2001042283A3 (en) Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
DE69325449D1 (de) Verfahren zur entwicklung von neuen pflanzentypen mit kapazität zur stickstoffbindung ebenfalls in deren blättern
DE68917642D1 (de) Verfahren zur kontinuierlichen Züchtung von haftenden tierischen Zellen.
DE3575743D1 (de) Verfahren zur gewinnung von phenylalanin-dehydrogenase enthaltenden mikroorganismen und deren verwendung zur herstellung von l-alpha-aminosaeuren.
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
DE3678552D1 (de) Verfahren zur herstellung von proteinen unter verwendung von transformierten milchsaeurebakterien.
DE3787044D1 (de) Transformant einer tierischen zelle, verfahren zur herstellung des transformanten und dessen verwendung zur praeparation eines gewuenschten fremdgenproduktes.
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE69941789D1 (de) In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten
ATE288476T1 (de) Herstellung von proteinen
ATE312195T1 (de) Verfahren zur herstellung von fremden proteinen
ATE384790T1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.
RU96123779A (ru) Способ получения иммуностимулятора
TH44443A (th) วิธีการสำหรับการให้องค์ประกอบจุลชีพที่มีชีวิตสำหรับสัตว์ปีก

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1085083

Country of ref document: EP